Infrastructure

Regulatory Approvals

Continuously filing DMFs and ANDAs in respective regulated and semi-regulated markets.

Type of Facility	Location	Capacity	Approval from
API - Paracetamol/Acetaminophen	Bonthapally	8000 MTPA Capacity (+ 2,000 starting in November 2009)	U.S.FDA, WHO GMP, EU, and COS Regulatory Authorities
API	Jeedimetla	Metformin – 960 MTPA Guaifenesin – 780 MTPA Methocarbamol – 96 MTPA Phenazopyridine – 50 MTPA	U.S. FDA, KFDA, TGA, and EDQM Regulatory Authorities
PFI - Multiple Small Volume Facility	Jeedimetla	1800 MTPA	U.S. FDA, KFDA, TGA, and EDQM Regulatory Authorities
PFI	Gagillapur	7200 MTPA	EU , GHCA , and TGA Regulatory Authorities
Formulation	Gagillapur	6 billion tablets per annum (Scalable to 12 billion tablets per annum)	Infarmed (EU), TGA
API - Ibuprofen	Wuhan, China	4800 MTPA	U.S. FDA, EDQM, TGA, Russian Authority, and MCC Regulatory Authorities